Helicobacter pylori eradication therapy (Q37721423)

22 August 2017

1 reference

title

Helicobacter pylori eradication therapy (English)

1 reference

Helicobacter pylori infectious disease

22 August 2017

0 references

1 reference

3

Toshifumi Hibi

1 reference

22 August 2017

Hidekazu Suzuki

1

1 reference

PubMed ID

20353303

22 August 2017

Toshihiro Nishizawa

series ordinal

2

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

22 August 2017

5

1 reference

22 August 2017

639-648

1 reference

22 August 2017

4

1 reference

Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils.

22 August 2017

1 reference

Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.

21 January 2018

1 reference

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification

21 January 2018

1 reference

Helicobacter pylori: present status and future prospects in Japan

21 January 2018

1 reference

High eradication rates of Helicobacter pylori with a new sequential treatment

21 January 2018

1 reference

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

21 January 2018

1 reference

Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico

21 January 2018

1 reference

Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States

21 January 2018

1 reference

Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis

21 January 2018

1 reference

Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000.

21 January 2018

1 reference

Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital

21 January 2018

1 reference

Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada

21 January 2018

1 reference

Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan.

21 January 2018

1 reference

'Rescue' therapies for the management of Helicobacter pylori infection

21 January 2018

1 reference

Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance

21 January 2018

1 reference

Alpha-ketoglutarate oxidoreductase, an essential salvage enzyme of energy metabolism, in coccoid form of Helicobacter pylori

21 January 2018

1 reference

A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori

21 January 2018

1 reference

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

Primary resistance in Helicobacter pylori isolated in children from Iran

21 January 2018

1 reference

Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria

21 January 2018

1 reference

Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt

21 January 2018

1 reference

Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.

21 January 2018

1 reference

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

21 January 2018

1 reference

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

21 January 2018

1 reference

Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures

21 January 2018

1 reference

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

21 January 2018

1 reference

Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication

21 January 2018

1 reference

Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori

21 January 2018

1 reference

The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice

21 January 2018

1 reference

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients

21 January 2018

1 reference

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

21 January 2018

1 reference

Furazolidone therapy for Helicobacter pylori: is it effective and safe?

21 January 2018

1 reference

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

21 January 2018

1 reference

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

21 January 2018

1 reference

The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication

21 January 2018

1 reference

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.10.25

1 reference

22 August 2017

1 reference

PubMed ID

20353303